Basic Information
Basic information for FTX-223-12aa-2
Peptide Name FTX-223-12aa-2
Genome Position chrX:74203775-74203810[-]
Species Human
Peptide Sequence MASTAVLPTETS
Peptide Length 12
Unique No (FTX-202-12aa-2,FTX-210-12aa-4,FTX-218-12aa-1,FTX-224-12aa-2,FTX-228-12aa-2,FTX-229-12aa-1,FTX-231-12aa-1,FTX-233-12aa-2,FTX-236-12aa-3,FTX-238-12aa-2,FTX-241-12aa-1,FTX-245-12aa-2,FTX-257-12aa-2,FTX-261-12aa-1,FTX-264-12aa-1,FTX-266-12aa-2,FTX-268-12aa)
Grand Average of Hydropathicity 0.3917
Relative Molecular Mass 1405.63
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000651936;FTX-223
Transcript Length 1768
Coding Ability 0.5554
DNA Sequence Corresponding to Peptide ATGGCCTCTACTGCTGTCCTACCAACAGAAACTTCA
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :